Management of Upper Respiratory Infections

Understanding Upper Respiratory Infections (URIs)

• Most cases of uncomplicated upper respiratory tract infections in adults are viral in origin and resolve spontaneously within 1-2 weeks 1
• Symptoms typically last one to two weeks, with most patients feeling better within the first week 1
• Complications such as bacterial rhinosinusitis or bacterial pneumonia are rare 1
• The presence of purulent nasal discharge or sputum does not predict bacterial infection 1

Why Azithromycin Is Not Appropriate for Most URIs

• Antibiotic treatment of adults with nonspecific upper respiratory tract infection does not enhance illness resolution or alter the rates of uncommon complications 1
• Antibiotic therapy does not decrease the duration of symptoms, reduce lost work time, or prevent complications 1
• More than 80% of ambulatory care visits for sinusitis result in an antibiotic prescription, with macrolides (like azithromycin) being most commonly prescribed (42%), despite most of these prescriptions being unnecessary 2
• Unnecessary antibiotic use contributes to antibiotic resistance, which is a significant public health concern 1
• Previous antibiotic use is the most important factor in carriage of and infection with antibiotic-resistant Streptococcus pneumoniae 1

When Antibiotics Might Be Considered

• If bacterial sinusitis is suspected, which is more likely when symptoms persist for more than 10 days without clinical improvement 2
• If bacterial sinusitis is suspected, which is more likely when symptoms are severe (fever >39°C, purulent nasal discharge, or facial pain lasting for >3 consecutive days) 2
• If bacterial sinusitis is suspected, which is more likely when symptoms worsen after an initial period of improvement (double sickening) for more than 3 days 2
• If community-acquired pneumonia is suspected, Amoxicillin is the reference treatment for pneumococcal pneumonia 3
• If community-acquired pneumonia is suspected, Macrolides (like azithromycin) may be reasonable for atypical bacteria such as Mycoplasma pneumoniae or Chlamydia pneumoniae 4, 3

Potential Harms of Inappropriate Antibiotic Use

• Adverse effects: Most patients diagnosed with acute rhinosinusitis have more adverse effects than benefits from antibiotics (number needed to harm = 8) 2
• Increased risk of antibiotic resistance in the community 1, 5
• Risk of Clostridium difficile infection, with recent antibiotic exposure as an important risk factor 5

Recommended Approach for URIs Lasting 1.5 Weeks

• Focus on supportive care and symptom management 2
• Consider analgesics for pain and antipyretics for fever 2
• Additional therapies that may provide symptomatic relief include systemic or topical decongestants 2
• Additional therapies that may provide symptomatic relief include saline nasal irrigation 2
• Additional therapies that may provide symptomatic relief include mucolytics 2
• Additional therapies that may provide symptomatic relief include intranasal corticosteroids 2
• Additional therapies that may provide symptomatic relief include antihistamines tailored to the patient's symptoms 2
• If symptoms persist beyond 10 days without improvement, worsen after initial improvement, or are severe (high fever, severe pain), reassessment may be warranted to consider bacterial sinusitis or other complications 2

Antibiotic Stewardship for Uncomplicated Upper Respiratory Infections

Lack of Clinical Benefit

• In otherwise healthy adults, prescribing antibiotics for uncomplicated upper respiratory infections provides no clinical benefit and exposes patients to adverse effects and the development of antibiotic resistance. [6][7]

Viral Etiology of Most URIs

• Respiratory viruses are responsible for 80 %–95 % of acute upper respiratory infections, rendering any antibiotic therapy ineffective regardless of the drug chosen. 8

No Benefit from Treating Purulent Secretions

• The presence of purulent (green/yellow) nasal discharge or sputum does not indicate bacterial infection, and patients with such secretions do not experience clinical improvement from antibiotics. 8

Harms of Inappropriate Antibiotic Use

These harms are associated with outpatient antibiotic prescriptions for upper respiratory infections. [6][7]

When to Consider Bacterial Complications (Exceptions)

Acute Bacterial Sinusitis

• Antibiotics may be considered only if any of the following are present:

[6][7]

Confirmed Group A Streptococcal Pharyngitis

• Antibiotic therapy is appropriate only after laboratory confirmation (rapid antigen detection test or throat culture).
• Testing should be limited to patients with persistent fever, anterior cervical adenitis, and tonsillar exudates.

[6][7]

Clinical Pitfalls to Avoid

• Do not prescribe antibiotics based solely on purulent nasal discharge; this finding occurs in the vast majority of viral URIs and does not predict bacterial infection. 8
• Do not assume antibiotics will accelerate recovery; they provide no benefit for uncomplicated viral upper respiratory infections. 8

Special Populations

• In patients with immunocompromising conditions, the standard recommendation against routine antibiotics for uncomplicated URIs may not apply and individualized management is required. 8

Antibiotic Prescribing Guidelines for Cough and Upper‑Respiratory Infections

1. Situations in Which Antibiotics Are Not Indicated

• Antibiotics should not be prescribed for the common cold, acute bronchitis, or uncomplicated acute cough because these conditions are viral, provide no clinical benefit, and are associated with significant adverse effects. [9][10]11
• In patients with common‑cold symptoms (rhinorrhea, nasal congestion, sneezing, sore throat, cough, low‑grade fever, headache, malaise) antibiotics do not shorten symptom duration, prevent bacterial complications (sinusitis, otitis media, asthma exacerbation), or reduce work‑time loss. 12
• The number needed to harm (NNH) for antibiotics in viral upper‑respiratory infections is 8, whereas the number needed to treat (NNT) for a rapid cure is 18, indicating that harms outweigh any modest benefit. 12
• Routine antibiotic therapy for uncomplicated acute bronchitis is not recommended regardless of cough duration. 10
• Antibiotics are not indicated for acute bronchitis, asthma, or mild exacerbations of chronic bronchitis caused by smoking or environmental irritants. [9][11]13
• Most acute bronchitis is viral and self‑limited, typically resolving within 10–14 days. 10
• Acute cough lasting < 4 weeks usually peaks in the first few days of a viral infection and improves gradually over 1–2 weeks; no antibiotics are required. [9][11]13
• Symptomatic relief for acute viral cough can be achieved with a first‑generation antihistamine/decongestant combination (e.g., brompheniramine + pseudoephedrine) or an NSAID such as naproxen; newer nonsedating antihistamines have not shown efficacy. [9][11][13][14]

2. Situations in Which Antibiotics Are Indicated

• Antibiotic therapy is appropriate when clinical findings suggest bacterial pneumonia (fever, tachypnea, rales, hypoxia, and a chest‑radiograph infiltrate). [9][11]13
• For acute bacterial sinusitis, antibiotics should be reserved for patients who meet any of the following:
  
  • Persistent symptoms > 10 days without improvement. [12][15]
  • Severe presentation: fever ≥ 39 °C and purulent nasal discharge or facial pain lasting ≥ 3 consecutive days. 12
  • “Double sickening”: worsening after an initial period of improvement (typically after 5–7 days). [12][15]
• Bacterial sinusitis should not be diagnosed during the first week of symptoms because viral rhinosinusitis produces sinus imaging abnormalities in ≈ 87 % of patients. [14][16]
• First‑line agents for acute bacterial sinusitis are amoxicillin or amoxicillin‑clavulanate. 15
• For confirmed Group A Streptococcal pharyngitis, penicillin or amoxicillin are first‑line antibiotics. 15
• Early administration of antibiotics (macrolides such as azithromycin or clarithromycin) is effective for Bordetella pertussis infection. [9][11][13][15]
• In exacerbations of bronchiectasis and severe chronic bronchitis in current or former smokers with marked airflow obstruction, antibiotics may provide benefit. [9][11]13

3. Clinical Decision‑Making Algorithm

• Week 1 of symptoms – Assume a viral etiology; provide only symptomatic treatment and do not prescribe antibiotics. 12
• Days 7–10 – If symptoms are improving, continue supportive care; if unchanged, maintain observation without antibiotics. 12
• Day 10 + – Persistent symptoms without improvement warrant evaluation for bacterial sinusitis and initiation of antibiotics if criteria are met. [12][15]
• Any time point – Presence of severe sinusitis criteria (fever ≥ 39 °C + purulent discharge + facial pain ≥ 3 days) or a biphasic (worsening after initial improvement) course should prompt antibiotic therapy for bacterial sinusitis. [12][15]
• Suspected bacterial pneumonia at any stage should lead to immediate antibiotic prescription. [9][11]

4. Harms of Inappropriate Antibiotic Use

• Adults treated with antibiotics for the common cold have a 3.6‑fold increased risk of adverse effects such as diarrhea, rash, and nausea. 14
• Prior antibiotic exposure raises the likelihood of colonization and infection with antibiotic‑resistant organisms. 10

5. Common Pitfalls to Avoid

• Do not base antibiotic prescribing solely on the presence of purulent nasal discharge, as this is common in viral upper‑respiratory infections. 12
• Avoid diagnosing bacterial sinusitis within the first 7 days of illness because viral infections can produce identical sinus imaging findings. [14][16]
• Do not assume antibiotics will accelerate recovery from viral infections; evidence shows no benefit. 12
• Do not use cough duration alone as an indication for antibiotics; viral coughs can naturally persist for 10–14 days. [9][10]11